✦ LIBER ✦

An international double-blind placebo-controlled trial of lamivudine in 286 children with chronic hepatitis B (CHB)

✍ Scribed by E.M. Sokal; D. Kelly; J. Mizerski; I. Badia; J. Areias; K. Schwarz; N. Little; S. Bell; M.J. Greensmith; M. Jonas

Book ID: 119526897
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 135 KB
Volume: 34
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(01)80942-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, double-blind, placebo-contro

Randomized, double-blind, placebo-controlled trial of bovine lactoferrin in patients with chronic hepatitis C

✍ Hideki Ueno; Tosiya Sato; Seiichiro Yamamoto; Katsuaki Tanaka; Shinichi Ohkawa; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

Randomised, double-blind, placebo-contro

Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C

✍ Olle Reichard; Gunnar Norkrans; Aril Frydén; Jean-Henrik Braconier; Anders Sönne 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 77 KB

220 Effects of lamivudine on disease pro

220 Effects of lamivudine on disease progression and development of liver cancer in advanced chronic hepatitis B: a prospective double-blind placebo-controlled clinical trial

✍ Yun-Fan Liaw; Joseph J.Y. Sung; Wan Chen Chow; Kelly Shue; Geoff Farrell 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 294 KB

Double-Blind, Placebo-Controlled Trial o

Double-Blind, Placebo-Controlled Trial of Famotidine in Children with Abdominal Pain and Dyspepsia

✍ Mary C. See; Audrey H. Birnbaum; Clyde B. Schechter; Marvin M. Goldenberg; Keith 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 83 KB

Double-blind placebo controlled clinical

Double-blind placebo controlled clinical trial of almitrine bismesylate in patients with chronic respiratory insufficiency

✍ I. Bakran; B. Vrhovac; B. Štangl; Đ. Tabori; A. Ivičevic; V. Todič; F. Kandare 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 518 KB

The efficacy and safety of almitrine bismesylate, a new respiratory stimulant, in patients with the hypoxaemic form of chronic respiratory insufficiency caused by chronic bronchitis and emphysema has been assessed. The multicentre trial of 12 weeks duration was double-blind and placebo controlled, w

A randomised, double blind, placebo cont

A randomised, double blind, placebo controlled trial of interferon alpha2b with and without ribavirin in mild chronic hepatitis C infection

✍ H. Verbaan; S. Lindgren; A. Widell 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 126 KB